Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone iodine + sodium fluoride is a topical combination drug, typically formulated as a varnish or solution for direct application to teeth. It combines two agents: povidone-iodine, a broad-spectrum antiseptic releasing iodine to disrupt microbial cell membranes, and sodium fluoride, which helps remineralize enamel and prevent dental caries. Used primarily in pediatric dentistry, particularly for high-risk children with early childhood caries (ECC), the combination provides immediate bactericidal effects against cariogenic bacteria (notably Streptococcus mutans) and augments enamel resistance to acid attack and remineralization. This dual-action strategy aims to reduce both microbial load and lesion progression. Clinical studies indicate improved caries prevention compared with fluoride alone[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone iodine + sodium fluoride.